Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Working Capital/Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 33.629.592.403.704.53

What is the latest Working Capital/Sales ratio of MANKIND PHARMA ?

The latest Working Capital/Sales ratio of MANKIND PHARMA is 33.62 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar202633.62
Mar20259.59
Mar20242.40
Mar20233.70
Mar20224.53

How is Working Capital/Sales of MANKIND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2026 33.62
250.57
Mar2025 9.59
299.58
Mar2024 2.4
-35.14
Mar2023 3.7
-18.32
Mar2022 4.53 -

Other Financial Ratios of MANKIND PHARMA


Compare Working Capital/Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹91,562.1 Cr -2.6% -10.6% -7.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.6%

-10.6%

-7.3%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses